Parkman Healthcare Partners LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parkman Healthcare Partners LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,491,224
-30.9%
111,802
-35.9%
1.19%
-27.0%
Q2 2023$9,392,097
+136.5%
174,477
+74.5%
1.63%
+88.4%
Q1 2023$3,972,000
-22.2%
100,000
-21.2%
0.86%
-36.4%
Q4 2022$5,104,141
+34.6%
126,874
+7.6%
1.36%
+26.1%
Q3 2022$3,791,000
+17.7%
117,941
+8.6%
1.08%
-9.1%
Q2 2022$3,221,000
+6.2%
108,559
+0.6%
1.19%
+33.6%
Q1 2022$3,033,000
-52.0%
107,911
-21.4%
0.89%
-36.3%
Q4 2021$6,323,000
+125.7%
137,226
+60.8%
1.40%
+96.8%
Q3 2021$2,801,000
+44.4%
85,346
+54.2%
0.71%
+67.2%
Q2 2021$1,940,00055,3460.42%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders